Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation

Coronary artery disease (CAD) is a common co-morbidity in transcatheter aortic valve implantation (TAVI) patients, but the prognostic value of coronary revascularization before TAVI is currently unknown. The aim of the present study was to assess the impact of coronary revascularization in patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2019-03, Vol.123 (6), p.948-955
Hauptverfasser: López Otero, Diego, Ávila-Carrillo, Alejandro, González Ferreiro, Rocío, Cid Menéndez, Adrián, Iglesias Álvarez, Diego, Álvarez Rodríguez, Leyre, Antúnez Muiños, Pablo, Álvarez, Belén Cid, Sanmartín Pena, Xoan Carlos, Gómez Pérez, Fernando, Diéguez, Alfredo Redondo, Cruz-González, Ignacio, Trillo Nouche, Ramiro, González-Juanatey, José Ramón
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 955
container_issue 6
container_start_page 948
container_title The American journal of cardiology
container_volume 123
creator López Otero, Diego
Ávila-Carrillo, Alejandro
González Ferreiro, Rocío
Cid Menéndez, Adrián
Iglesias Álvarez, Diego
Álvarez Rodríguez, Leyre
Antúnez Muiños, Pablo
Álvarez, Belén Cid
Sanmartín Pena, Xoan Carlos
Gómez Pérez, Fernando
Diéguez, Alfredo Redondo
Cruz-González, Ignacio
Trillo Nouche, Ramiro
González-Juanatey, José Ramón
description Coronary artery disease (CAD) is a common co-morbidity in transcatheter aortic valve implantation (TAVI) patients, but the prognostic value of coronary revascularization before TAVI is currently unknown. The aim of the present study was to assess the impact of coronary revascularization in patients who underwent TAVI. Patients underwent TAVI from 2008 to 2016 were included in the study. Baseline SYNTAX score and residual SYNTAX score (rSS) after percutaneous coronary intervention were calculated. Based on rSS, patients were classified as complete revascularization (rSS = 0), reasonably incomplete revascularization (rSS >0 and
doi_str_mv 10.1016/j.amjcard.2018.12.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2162493341</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914918321969</els_id><sourcerecordid>2162493341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-b3922eb0dbe2d0c0273e56f75e7fe8fc6739299347ab30cbff5f6e1f1fe340fc3</originalsourceid><addsrcrecordid>eNqFkU9P3DAQxS1UBAvlI7Sy1EsvCf4TJ_EJoVVLkZCoKihHy3HGwlESb21nUfvpa9htD1w4zYz0mzej9xD6QElJCa3Ph1JPg9GhLxmhbUlZSUhzgFa0bWRBJeXv0IoQwgpJK3mMTmIc8kipqI_QMSdCtqxiK2Svp402CXuL1z74WYff-AdsdTTLqIP7o5PzM3Yz_p47mFPED48e3889hKc84rug52h0eoQEAV_6kJzBP_W4BZyVRz2nF4X36NDqMcLZvp6i-69f7tbfipvbq-v15U1huOSp6LhkDDrSd8B6YghrOIjaNgIaC601dZMBKXnV6I4T01krbA3UUgu8ItbwU_R5p7sJ_tcCManJRQNjfgT8EhWjNask5xXN6KdX6OCXMOfvMtUKIRmvRKbEjjLBxxjAqk1wU3ZJUaKeg1CD2gehnoNQlKkcRN77uFdfugn6_1v_nM_AxQ6AbMfWQVDRZIMN9C6ASar37o0TfwGc951n</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2185592345</pqid></control><display><type>article</type><title>Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>López Otero, Diego ; Ávila-Carrillo, Alejandro ; González Ferreiro, Rocío ; Cid Menéndez, Adrián ; Iglesias Álvarez, Diego ; Álvarez Rodríguez, Leyre ; Antúnez Muiños, Pablo ; Álvarez, Belén Cid ; Sanmartín Pena, Xoan Carlos ; Gómez Pérez, Fernando ; Diéguez, Alfredo Redondo ; Cruz-González, Ignacio ; Trillo Nouche, Ramiro ; González-Juanatey, José Ramón</creator><creatorcontrib>López Otero, Diego ; Ávila-Carrillo, Alejandro ; González Ferreiro, Rocío ; Cid Menéndez, Adrián ; Iglesias Álvarez, Diego ; Álvarez Rodríguez, Leyre ; Antúnez Muiños, Pablo ; Álvarez, Belén Cid ; Sanmartín Pena, Xoan Carlos ; Gómez Pérez, Fernando ; Diéguez, Alfredo Redondo ; Cruz-González, Ignacio ; Trillo Nouche, Ramiro ; González-Juanatey, José Ramón</creatorcontrib><description>Coronary artery disease (CAD) is a common co-morbidity in transcatheter aortic valve implantation (TAVI) patients, but the prognostic value of coronary revascularization before TAVI is currently unknown. The aim of the present study was to assess the impact of coronary revascularization in patients who underwent TAVI. Patients underwent TAVI from 2008 to 2016 were included in the study. Baseline SYNTAX score and residual SYNTAX score (rSS) after percutaneous coronary intervention were calculated. Based on rSS, patients were classified as complete revascularization (rSS = 0), reasonably incomplete revascularization (rSS &gt;0 and &lt;8), and incomplete revascularization (rSS ≥8). The primary objective was to evaluate the impact of CAD and rSS on major cardiovascular adverse events (MACEs). The secondary objective was to assess the impact of rSS on hospitalization for heart failure. A total of 349 patients (mean age 82.4 ± 5.7 years, 53% women) were included in the study. A total of 187 patients (53.6%) had CAD (mean baseline SYNTAX score 9.2 ± 8.1). Percutaneous coronary intervention was performed in 29.9% of patients, achieving reasonably incomplete revascularization in 45.4%, and incomplete revascularization in 24.5%. The mean follow-up was 35.2 ± 25.3 months. No differences were observed in MACE rate between the CAD and non-CAD groups, or between the different degrees of revascularization. Differences were also not seen in the different levels of revascularization and hospitalization due to heart failure. In patients who underwent TAVI in this study, no association was found between the presence of CAD or the degree of revascularization in a long-term follow-up.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2018.12.007</identifier><identifier>PMID: 30598242</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged, 80 and over ; Aortic valve ; Aortic Valve Stenosis - diagnosis ; Aortic Valve Stenosis - epidemiology ; Aortic Valve Stenosis - surgery ; Cardiology ; Cardiovascular disease ; Clinical medicine ; Comorbidity ; Congestive heart failure ; Coronary Angiography ; Coronary artery ; Coronary artery disease ; Coronary Artery Disease - diagnosis ; Coronary Artery Disease - epidemiology ; Coronary Artery Disease - surgery ; Coronary vessels ; Echocardiography ; Female ; Follow-Up Studies ; Heart ; Heart failure ; Humans ; Implantation ; Intervention ; Male ; Medical prognosis ; Morbidity ; Patients ; Percutaneous Coronary Intervention - methods ; Prognosis ; Registries ; Retrospective Studies ; Rheumatic heart disease ; Risk Assessment - methods ; Risk Factors ; Severity of Illness Index ; Spain - epidemiology ; Stents ; Survival Rate - trends ; Syntax ; Time Factors ; Transcatheter Aortic Valve Replacement - methods ; Transplants &amp; implants ; Variables</subject><ispartof>The American journal of cardiology, 2019-03, Vol.123 (6), p.948-955</ispartof><rights>2018 Elsevier Inc.</rights><rights>Copyright © 2018 Elsevier Inc. All rights reserved.</rights><rights>2018. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-b3922eb0dbe2d0c0273e56f75e7fe8fc6739299347ab30cbff5f6e1f1fe340fc3</citedby><cites>FETCH-LOGICAL-c393t-b3922eb0dbe2d0c0273e56f75e7fe8fc6739299347ab30cbff5f6e1f1fe340fc3</cites><orcidid>0000-0001-8312-4874</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2185592345?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30598242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>López Otero, Diego</creatorcontrib><creatorcontrib>Ávila-Carrillo, Alejandro</creatorcontrib><creatorcontrib>González Ferreiro, Rocío</creatorcontrib><creatorcontrib>Cid Menéndez, Adrián</creatorcontrib><creatorcontrib>Iglesias Álvarez, Diego</creatorcontrib><creatorcontrib>Álvarez Rodríguez, Leyre</creatorcontrib><creatorcontrib>Antúnez Muiños, Pablo</creatorcontrib><creatorcontrib>Álvarez, Belén Cid</creatorcontrib><creatorcontrib>Sanmartín Pena, Xoan Carlos</creatorcontrib><creatorcontrib>Gómez Pérez, Fernando</creatorcontrib><creatorcontrib>Diéguez, Alfredo Redondo</creatorcontrib><creatorcontrib>Cruz-González, Ignacio</creatorcontrib><creatorcontrib>Trillo Nouche, Ramiro</creatorcontrib><creatorcontrib>González-Juanatey, José Ramón</creatorcontrib><title>Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Coronary artery disease (CAD) is a common co-morbidity in transcatheter aortic valve implantation (TAVI) patients, but the prognostic value of coronary revascularization before TAVI is currently unknown. The aim of the present study was to assess the impact of coronary revascularization in patients who underwent TAVI. Patients underwent TAVI from 2008 to 2016 were included in the study. Baseline SYNTAX score and residual SYNTAX score (rSS) after percutaneous coronary intervention were calculated. Based on rSS, patients were classified as complete revascularization (rSS = 0), reasonably incomplete revascularization (rSS &gt;0 and &lt;8), and incomplete revascularization (rSS ≥8). The primary objective was to evaluate the impact of CAD and rSS on major cardiovascular adverse events (MACEs). The secondary objective was to assess the impact of rSS on hospitalization for heart failure. A total of 349 patients (mean age 82.4 ± 5.7 years, 53% women) were included in the study. A total of 187 patients (53.6%) had CAD (mean baseline SYNTAX score 9.2 ± 8.1). Percutaneous coronary intervention was performed in 29.9% of patients, achieving reasonably incomplete revascularization in 45.4%, and incomplete revascularization in 24.5%. The mean follow-up was 35.2 ± 25.3 months. No differences were observed in MACE rate between the CAD and non-CAD groups, or between the different degrees of revascularization. Differences were also not seen in the different levels of revascularization and hospitalization due to heart failure. In patients who underwent TAVI in this study, no association was found between the presence of CAD or the degree of revascularization in a long-term follow-up.</description><subject>Aged, 80 and over</subject><subject>Aortic valve</subject><subject>Aortic Valve Stenosis - diagnosis</subject><subject>Aortic Valve Stenosis - epidemiology</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Clinical medicine</subject><subject>Comorbidity</subject><subject>Congestive heart failure</subject><subject>Coronary Angiography</subject><subject>Coronary artery</subject><subject>Coronary artery disease</subject><subject>Coronary Artery Disease - diagnosis</subject><subject>Coronary Artery Disease - epidemiology</subject><subject>Coronary Artery Disease - surgery</subject><subject>Coronary vessels</subject><subject>Echocardiography</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart</subject><subject>Heart failure</subject><subject>Humans</subject><subject>Implantation</subject><subject>Intervention</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Morbidity</subject><subject>Patients</subject><subject>Percutaneous Coronary Intervention - methods</subject><subject>Prognosis</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Rheumatic heart disease</subject><subject>Risk Assessment - methods</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Spain - epidemiology</subject><subject>Stents</subject><subject>Survival Rate - trends</subject><subject>Syntax</subject><subject>Time Factors</subject><subject>Transcatheter Aortic Valve Replacement - methods</subject><subject>Transplants &amp; implants</subject><subject>Variables</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkU9P3DAQxS1UBAvlI7Sy1EsvCf4TJ_EJoVVLkZCoKihHy3HGwlESb21nUfvpa9htD1w4zYz0mzej9xD6QElJCa3Ph1JPg9GhLxmhbUlZSUhzgFa0bWRBJeXv0IoQwgpJK3mMTmIc8kipqI_QMSdCtqxiK2Svp402CXuL1z74WYff-AdsdTTLqIP7o5PzM3Yz_p47mFPED48e3889hKc84rug52h0eoQEAV_6kJzBP_W4BZyVRz2nF4X36NDqMcLZvp6i-69f7tbfipvbq-v15U1huOSp6LhkDDrSd8B6YghrOIjaNgIaC601dZMBKXnV6I4T01krbA3UUgu8ItbwU_R5p7sJ_tcCManJRQNjfgT8EhWjNask5xXN6KdX6OCXMOfvMtUKIRmvRKbEjjLBxxjAqk1wU3ZJUaKeg1CD2gehnoNQlKkcRN77uFdfugn6_1v_nM_AxQ6AbMfWQVDRZIMN9C6ASar37o0TfwGc951n</recordid><startdate>20190315</startdate><enddate>20190315</enddate><creator>López Otero, Diego</creator><creator>Ávila-Carrillo, Alejandro</creator><creator>González Ferreiro, Rocío</creator><creator>Cid Menéndez, Adrián</creator><creator>Iglesias Álvarez, Diego</creator><creator>Álvarez Rodríguez, Leyre</creator><creator>Antúnez Muiños, Pablo</creator><creator>Álvarez, Belén Cid</creator><creator>Sanmartín Pena, Xoan Carlos</creator><creator>Gómez Pérez, Fernando</creator><creator>Diéguez, Alfredo Redondo</creator><creator>Cruz-González, Ignacio</creator><creator>Trillo Nouche, Ramiro</creator><creator>González-Juanatey, José Ramón</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8312-4874</orcidid></search><sort><creationdate>20190315</creationdate><title>Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation</title><author>López Otero, Diego ; Ávila-Carrillo, Alejandro ; González Ferreiro, Rocío ; Cid Menéndez, Adrián ; Iglesias Álvarez, Diego ; Álvarez Rodríguez, Leyre ; Antúnez Muiños, Pablo ; Álvarez, Belén Cid ; Sanmartín Pena, Xoan Carlos ; Gómez Pérez, Fernando ; Diéguez, Alfredo Redondo ; Cruz-González, Ignacio ; Trillo Nouche, Ramiro ; González-Juanatey, José Ramón</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-b3922eb0dbe2d0c0273e56f75e7fe8fc6739299347ab30cbff5f6e1f1fe340fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged, 80 and over</topic><topic>Aortic valve</topic><topic>Aortic Valve Stenosis - diagnosis</topic><topic>Aortic Valve Stenosis - epidemiology</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Clinical medicine</topic><topic>Comorbidity</topic><topic>Congestive heart failure</topic><topic>Coronary Angiography</topic><topic>Coronary artery</topic><topic>Coronary artery disease</topic><topic>Coronary Artery Disease - diagnosis</topic><topic>Coronary Artery Disease - epidemiology</topic><topic>Coronary Artery Disease - surgery</topic><topic>Coronary vessels</topic><topic>Echocardiography</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart</topic><topic>Heart failure</topic><topic>Humans</topic><topic>Implantation</topic><topic>Intervention</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Morbidity</topic><topic>Patients</topic><topic>Percutaneous Coronary Intervention - methods</topic><topic>Prognosis</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Rheumatic heart disease</topic><topic>Risk Assessment - methods</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Spain - epidemiology</topic><topic>Stents</topic><topic>Survival Rate - trends</topic><topic>Syntax</topic><topic>Time Factors</topic><topic>Transcatheter Aortic Valve Replacement - methods</topic><topic>Transplants &amp; implants</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>López Otero, Diego</creatorcontrib><creatorcontrib>Ávila-Carrillo, Alejandro</creatorcontrib><creatorcontrib>González Ferreiro, Rocío</creatorcontrib><creatorcontrib>Cid Menéndez, Adrián</creatorcontrib><creatorcontrib>Iglesias Álvarez, Diego</creatorcontrib><creatorcontrib>Álvarez Rodríguez, Leyre</creatorcontrib><creatorcontrib>Antúnez Muiños, Pablo</creatorcontrib><creatorcontrib>Álvarez, Belén Cid</creatorcontrib><creatorcontrib>Sanmartín Pena, Xoan Carlos</creatorcontrib><creatorcontrib>Gómez Pérez, Fernando</creatorcontrib><creatorcontrib>Diéguez, Alfredo Redondo</creatorcontrib><creatorcontrib>Cruz-González, Ignacio</creatorcontrib><creatorcontrib>Trillo Nouche, Ramiro</creatorcontrib><creatorcontrib>González-Juanatey, José Ramón</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>López Otero, Diego</au><au>Ávila-Carrillo, Alejandro</au><au>González Ferreiro, Rocío</au><au>Cid Menéndez, Adrián</au><au>Iglesias Álvarez, Diego</au><au>Álvarez Rodríguez, Leyre</au><au>Antúnez Muiños, Pablo</au><au>Álvarez, Belén Cid</au><au>Sanmartín Pena, Xoan Carlos</au><au>Gómez Pérez, Fernando</au><au>Diéguez, Alfredo Redondo</au><au>Cruz-González, Ignacio</au><au>Trillo Nouche, Ramiro</au><au>González-Juanatey, José Ramón</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2019-03-15</date><risdate>2019</risdate><volume>123</volume><issue>6</issue><spage>948</spage><epage>955</epage><pages>948-955</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>Coronary artery disease (CAD) is a common co-morbidity in transcatheter aortic valve implantation (TAVI) patients, but the prognostic value of coronary revascularization before TAVI is currently unknown. The aim of the present study was to assess the impact of coronary revascularization in patients who underwent TAVI. Patients underwent TAVI from 2008 to 2016 were included in the study. Baseline SYNTAX score and residual SYNTAX score (rSS) after percutaneous coronary intervention were calculated. Based on rSS, patients were classified as complete revascularization (rSS = 0), reasonably incomplete revascularization (rSS &gt;0 and &lt;8), and incomplete revascularization (rSS ≥8). The primary objective was to evaluate the impact of CAD and rSS on major cardiovascular adverse events (MACEs). The secondary objective was to assess the impact of rSS on hospitalization for heart failure. A total of 349 patients (mean age 82.4 ± 5.7 years, 53% women) were included in the study. A total of 187 patients (53.6%) had CAD (mean baseline SYNTAX score 9.2 ± 8.1). Percutaneous coronary intervention was performed in 29.9% of patients, achieving reasonably incomplete revascularization in 45.4%, and incomplete revascularization in 24.5%. The mean follow-up was 35.2 ± 25.3 months. No differences were observed in MACE rate between the CAD and non-CAD groups, or between the different degrees of revascularization. Differences were also not seen in the different levels of revascularization and hospitalization due to heart failure. In patients who underwent TAVI in this study, no association was found between the presence of CAD or the degree of revascularization in a long-term follow-up.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30598242</pmid><doi>10.1016/j.amjcard.2018.12.007</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-8312-4874</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2019-03, Vol.123 (6), p.948-955
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_2162493341
source MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland
subjects Aged, 80 and over
Aortic valve
Aortic Valve Stenosis - diagnosis
Aortic Valve Stenosis - epidemiology
Aortic Valve Stenosis - surgery
Cardiology
Cardiovascular disease
Clinical medicine
Comorbidity
Congestive heart failure
Coronary Angiography
Coronary artery
Coronary artery disease
Coronary Artery Disease - diagnosis
Coronary Artery Disease - epidemiology
Coronary Artery Disease - surgery
Coronary vessels
Echocardiography
Female
Follow-Up Studies
Heart
Heart failure
Humans
Implantation
Intervention
Male
Medical prognosis
Morbidity
Patients
Percutaneous Coronary Intervention - methods
Prognosis
Registries
Retrospective Studies
Rheumatic heart disease
Risk Assessment - methods
Risk Factors
Severity of Illness Index
Spain - epidemiology
Stents
Survival Rate - trends
Syntax
Time Factors
Transcatheter Aortic Valve Replacement - methods
Transplants & implants
Variables
title Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A26%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Coronary%20Revascularization%20in%20Patients%20Who%20Underwent%20Transcatheter%20Aortic%20Valve%20Implantation&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=L%C3%B3pez%20Otero,%20Diego&rft.date=2019-03-15&rft.volume=123&rft.issue=6&rft.spage=948&rft.epage=955&rft.pages=948-955&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2018.12.007&rft_dat=%3Cproquest_cross%3E2162493341%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2185592345&rft_id=info:pmid/30598242&rft_els_id=S0002914918321969&rfr_iscdi=true